These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1205 related articles for article (PubMed ID: 31159582)

  • 21. Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysis.
    Miller RJ; Howlett JG; Exner DV; Campbell PM; Grant AD; Wilton SB
    Can J Cardiol; 2015 Jun; 31(6):792-9. PubMed ID: 26022990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
    Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC
    Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials.
    Hansen MR; Hróbjartsson A; Videbæk L; Ennis ZN; Pareek M; Paulsen NH; Broe M; Olesen M; Pottegård A; Damkier P; Hallas J
    Am J Med; 2020 Jun; 133(6):e280-e289. PubMed ID: 32173347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
    Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA
    JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological therapy of heart failure with reduced ejection fraction].
    Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
    Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysis.
    Danielson C; Lileikyte G; Ouwerkerk W; S P Lam C; Erlinge D; Teng TK
    ESC Heart Fail; 2022 Aug; 9(4):2753-2761. PubMed ID: 35603531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of predictive modeling in implementing optimal heart failure therapy.
    Prasad H; Sra J; Levy WC; Stapleton DD
    Am J Med Sci; 2011 Mar; 341(3):185-90. PubMed ID: 21233695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
    Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
    Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.
    Zafeiropoulos S; Farmakis IT; Milioglou I; Doundoulakis I; Gorodeski EZ; Konstantinides SV; Cooper L; Zanos S; Stavrakis S; Giamouzis G; Butler J; Giannakoulas G
    JACC Heart Fail; 2024 Apr; 12(4):616-627. PubMed ID: 37656079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction.
    Park DY; An S; Attanasio S; Jolly N; Malhotra S; Doukky R; Samsky MD; Sen S; Ahmad T; Nanna MG; Vij A
    Am J Cardiol; 2023 Jan; 187():84-92. PubMed ID: 36459752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.
    Tromp J; Ouwerkerk W; van Veldhuisen DJ; Hillege HL; Richards AM; van der Meer P; Anand IS; Lam CSP; Voors AA
    JACC Heart Fail; 2022 Feb; 10(2):73-84. PubMed ID: 34895860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Sreenivasan J; Malik A; Khan MS; Lloji A; Hooda U; Aronow WS; Lanier GM; Pan S; Greene SJ; Murad MH; Michos ED; Cooper HA; Gass A; Gupta R; Desai NR; Mentz RJ; Frishman WH; Panza JA
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):114-123. PubMed ID: 36576372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MY APPROACH to treating heart failure with reduced ejection fraction.
    Greenberg BH
    Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
    Penn J; Goldenberg I; McNitt S; Polonsky B; Ruwald MH; Zareba W; Moss AJ; Alexis JD
    J Card Fail; 2015 Jul; 21(7):541-7. PubMed ID: 25800548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.
    Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Pannaux M; Swedberg K
    Eur J Heart Fail; 2018 Sep; 20(9):1315-1322. PubMed ID: 29806165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
    Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
    Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.